CVS HEALTHSPIRE Trademark

Trademark Overview

On Thursday, December 14, 2023, a trademark application was filed for CVS HEALTHSPIRE with the United States Patent and Trademark Office. The USPTO has given the CVS HEALTHSPIRE trademark a serial number of 98314674. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, April 7, 2026. This trademark is owned by CVS Pharmacy, Inc.. The CVS HEALTHSPIRE trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Custom manufacture of pharmaceutical products; Custom manufacture of pharmaceuticals, namely, generic prescription drugs
cvs healthspire

General Information

Serial Number98314674
Word MarkCVS HEALTHSPIRE
Filing DateThursday, December 14, 2023
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, April 7, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 8, 2024

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Pseudo MarkCVS HEALTH SPIRE
Goods and ServicesCustom manufacture of pharmaceutical products; Custom manufacture of pharmaceuticals, namely, generic prescription drugs
Description of MarkThe mark consists of the stylized wording "CVS HEALTHSPIRE" with a solid heart shape over the letter "I".

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, December 14, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCVS Pharmacy, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWoonsocket, RI 02895
US
Party NameCVS Pharmacy, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoonsocket, RI 02895
US

Trademark Events

Event DateEvent Description
Thursday, December 14, 2023NEW APPLICATION ENTERED
Friday, March 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 22, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, July 15, 2024ASSIGNED TO EXAMINER
Tuesday, July 16, 2024NON-FINAL ACTION WRITTEN
Tuesday, July 16, 2024NON-FINAL ACTION E-MAILED
Tuesday, July 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 27, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 27, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 27, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 3, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 18, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 8, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 8, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 19, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 3, 2025SOU TEAS EXTENSION RECEIVED
Thursday, April 3, 2025SOU EXTENSION 1 FILED
Thursday, April 3, 2025SOU EXTENSION 1 GRANTED
Friday, April 4, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 9, 2025SOU TEAS EXTENSION RECEIVED
Thursday, October 9, 2025SOU EXTENSION 2 FILED
Thursday, October 9, 2025SOU EXTENSION 2 GRANTED
Friday, October 10, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 7, 2026SOU TEAS EXTENSION RECEIVED
Tuesday, April 7, 2026SOU EXTENSION 3 FILED
Tuesday, April 7, 2026SOU EXTENSION 3 GRANTED
Wednesday, April 8, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

healthspire custom manufacture prescription drugs generic pharmaceuticals pharmaceutical products namely